4967 — Kobayashi Pharmaceutical Share Price
Last trade - 00:00- ¥541bn
- ¥477bn
- ¥166bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 42.26 | ||
| PEG Ratio (f) | 29.45 | ||
| EPS Growth (f) | 1.46% | ||
| Dividend Yield (f) | 1.5% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.59 | ||
| Price to Tang. Book | 2.82 | ||
| Price to Free Cashflow | 46.76 | ||
| Price to Sales | 3.23 | ||
| EV to EBITDA | 149.38 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -2.82% | ||
| Return on Equity | 0.78% | ||
| Operating Margin | -3.59% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 155,252 | 166,258 | 173,455 | 165,600 | 165,742 | 171,688 | 179,357 | 1.95% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +2 | +3.43 | +3.28 | +0.54 | -1.54 | -50.09 | +28.17 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
KOBAYASHI PHARMACEUTICAL CO.,LTD. is a Japan-based company that manufactures and sells healthcare products and daily necessities. It operates through two segments: Domestic Business segment and International Business segment. In the healthcare sector, it offers over-the-counter (OTC) medicines, oral hygiene products, and self-care-related items. In the daily necessities sector, it manufactures and sells air fresheners and deodorizers, sanitary products, miscellaneous goods, disposable heat packs, and food-related products. Additionally, the Company engages in transportation services, the manufacture and sale of synthetic resin containers, real estate management, and advertising planning and production.
Directors
- Kazumasa Kobayashi CHM (80)
- Akihiro Kobayashi PRE (49)
- Noriaki Hirao FID
- Satoshi Yamane SMD (61)
- Naoki Ayabe MEO
- Fujito Ohwaki MEO
- Atsushi Sato DSL
- Jun Sato DSL
- Kazuhito Miyanishi EXO (58)
- Takuya Matsushita EXO
- Tetsushi Nishioka EXO
- Yoshihiro Ogawa EXO
- Nobuo Sakuta EXO
- Kunio Ito IND (69)
- Kaori Sasaki IND (61)
- Haruo Tsuji IND (88)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- August 22nd, 1919
- Public Since
- April 20th, 1999
- No. of Shareholders
- 68,319
- No. of Employees
- 3,731
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 74,338,764
- Address
- KDX Kobayashi Doshomachi Bldg., OSAKA-SHI, 541-0045
- Web
- https://www.kobayashi.co.jp
- Phone
- +81 662311144
- Auditors
- Ernst & Young ShinNihon LLC
Latest News for 4967
Upcoming Events for 4967
Q3 2026 Kobayashi Pharmaceutical Co Ltd Earnings Release
Dividend For 4967.T - 61.0000 JPY
Full Year 2026 Kobayashi Pharmaceutical Co Ltd Earnings Release
Kobayashi Pharmaceutical Co Ltd Annual Shareholders Meeting
Similar to 4967
AB&Company
Tokyo Stock Exchange
Adjuvant Holdings
Tokyo Stock Exchange
AIAI
Tokyo Stock Exchange
Ai Robotics
Tokyo Stock Exchange
ALMADO
Tokyo Stock Exchange
FAQ
As of Today at 03:39 UTC, shares in Kobayashi Pharmaceutical are trading at ¥7,283. This share price information is delayed by 15 minutes.
Shares in Kobayashi Pharmaceutical last closed at ¥7,283 and the price had moved by +42.22% over the past 365 days. In terms of relative price strength the Kobayashi Pharmaceutical share price has outperformed the Nikkei 225 Index by +5.11% over the past year.
The overall consensus recommendation for Kobayashi Pharmaceutical is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Kobayashi Pharmaceutical dividend yield is 1.44% based on the trailing twelve month period.
Last year, Kobayashi Pharmaceutical paid a total dividend of ¥105, and it currently has a trailing dividend yield of 1.44%.Looking ahead, shares in Kobayashi Pharmaceutical are due to go ex-dividend on 2026-12-29 and the next dividend pay date is 2027-03-09.
Kobayashi Pharmaceutical are due to go ex-dividend on 2026-12-29 and the next dividend pay date is 2027-03-09. The historic dividend yield on Kobayashi Pharmaceutical shares is currently 1.44%.
To buy shares in Kobayashi Pharmaceutical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥7,283, shares in Kobayashi Pharmaceutical had a market capitalisation of ¥541bn.
Here are the trading details for Kobayashi Pharmaceutical:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4967
Based on an overall assessment of its quality, value and momentum Kobayashi Pharmaceutical is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Kobayashi Pharmaceutical is ¥5,521. That is 24.19% below the last closing price of ¥7,283.
Analysts covering Kobayashi Pharmaceutical currently have a consensus Earnings Per Share (EPS) forecast of ¥141 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kobayashi Pharmaceutical. Over the past six months, its share price has outperformed the Nikkei 225 Index by +10.69%.
As of the last closing price of ¥7,283, shares in Kobayashi Pharmaceutical were trading +26.75% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Kobayashi Pharmaceutical PE ratio based on its reported earnings over the past 12 months is 42.26. The shares last closed at ¥7,283.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Kobayashi Pharmaceutical's management team is headed by:
- Kazumasa Kobayashi - CHM
- Akihiro Kobayashi - PRE
- Noriaki Hirao - FID
- Satoshi Yamane - SMD
- Naoki Ayabe - MEO
- Fujito Ohwaki - MEO
- Atsushi Sato - DSL
- Jun Sato - DSL
- Kazuhito Miyanishi - EXO
- Takuya Matsushita - EXO
- Tetsushi Nishioka - EXO
- Yoshihiro Ogawa - EXO
- Nobuo Sakuta - EXO
- Kunio Ito - IND
- Kaori Sasaki - IND
- Haruo Tsuji - IND